Literature DB >> 16322220

The octamer binding transcription factor Oct-1 is a stress sensor.

Dean Tantin1, Caroline Schild-Poulter, Victoria Wang, Robert J G Haché, Phillip A Sharp.   

Abstract

The POU-domain transcription factor Oct-1 is widely expressed in adult tissues and has been proposed to regulate a large group of target genes. Microarray expression profiling was used to evaluate gene expression changes in Oct-1-deficient mouse fibroblasts. A number of genes associated with cellular stress exhibited altered expression. Consistent with this finding, Oct-1-deficient fibroblasts were hypersensitive to gamma radiation, doxorubicin, and hydrogen peroxide and harbored elevated reactive oxygen species. Expression profiling identified a second group of genes dysregulated in Oct-1-deficient fibroblasts following irradiation, including many associated with oxidative and metabolic stress. A number of these genes contain octamer sequences in their immediate 5' regulatory regions, some of which are conserved in human. These results indicate that Oct-1 modulates the activity of genes important for the cellular response to stress.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16322220     DOI: 10.1158/0008-5472.CAN-05-2399

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  53 in total

Review 1.  The Oct1 transcription factor and epithelial malignancies: Old protein learns new tricks.

Authors:  Karina Vázquez-Arreguín; Dean Tantin
Journal:  Biochim Biophys Acta       Date:  2016-02-10

2.  Negative regulation of human U6 snRNA promoter by p38 kinase through Oct-1.

Authors:  Bor-Ruei Lin; Ven Natarajan
Journal:  Gene       Date:  2012-01-28       Impact factor: 3.688

3.  Oct1 loss of function induces a coordinate metabolic shift that opposes tumorigenicity.

Authors:  Arvind Shakya; Robert Cooksey; James E Cox; Victoria Wang; Donald A McClain; Dean Tantin
Journal:  Nat Cell Biol       Date:  2009-02-15       Impact factor: 28.824

4.  A general mechanism for transcription regulation by Oct1 and Oct4 in response to genotoxic and oxidative stress.

Authors:  Jinsuk Kang; Matthew Gemberling; Mitsuhiro Nakamura; Frank G Whitby; Hiroshi Handa; William G Fairbrother; Dean Tantin
Journal:  Genes Dev       Date:  2009-01-15       Impact factor: 11.361

5.  Octamer transcription factor-1 induces the Warburg effect via up-regulation of hexokinase 2 in non-small cell lung cancer.

Authors:  Zhen Li; Jin Su; Mingming Sun; Jiaqi Song; Huanran Sun; Jun Fan; Guo Chen; Changliang Shan; Qi Qi; Shuai Zhang
Journal:  Mol Cell Biochem       Date:  2021-05-10       Impact factor: 3.396

6.  Genomic predictors of interindividual differences in response to DNA damaging agents.

Authors:  Rebecca C Fry; J Peter Svensson; Chandni Valiathan; Emma Wang; Brad J Hogan; Sanchita Bhattacharya; James M Bugni; Charles A Whittaker; Leona D Samson
Journal:  Genes Dev       Date:  2008-09-19       Impact factor: 11.361

7.  Cellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latency.

Authors:  Amanda R Robinson; Swee Sen Kwek; Stacy R Hagemeier; Coral K Wille; Shannon C Kenney
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

8.  OCT-1 overexpression is associated with poor prognosis in patients with well-differentiated gastric cancer.

Authors:  Sang-Ho Jeong; Young-Joon Lee; Bok-Im Cho; Woo-Song Ha; Sang-Kyung Choi; Eun-Jung Jung; Young-Tae Ju; Chi-Young Jeong; Gyung Hyuck Ko; Jiyun Yoo; Soon-Chan Hong
Journal:  Tumour Biol       Date:  2014-02-25

9.  Proteomic 2D DIGE profiling of human vascular endothelial cells exposed to environmentally relevant concentration of endocrine disruptor PCB153 and physiological concentration of 17β-estradiol.

Authors:  Quentin Felty
Journal:  Cell Biol Toxicol       Date:  2010-07-11       Impact factor: 6.691

10.  Regulation of Oct1/Pou2f1 transcription activity by O-GlcNAcylation.

Authors:  Jinsuk Kang; Zuolian Shen; Jae-Min Lim; Hiroshi Handa; Lance Wells; Dean Tantin
Journal:  FASEB J       Date:  2013-04-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.